Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_4
2
29%
Ph phase_3
3
43%
Ph not_applicable
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (50.0%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

completed571%
terminated229%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_4

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

NCT06081283
completed

Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients

NCT03712254
completedphase_3

Established Status Epilepticus Treatment Trial

NCT01960075
completedphase_3

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

NCT01870024
terminatednot_applicable

A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide

NCT01110187
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06081283Phase 4

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

Terminated
NCT03712254

Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients

Completed
NCT01960075Phase 3

Established Status Epilepticus Treatment Trial

Completed
NCT01870024Phase 3

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

Completed
NCT01110187Not Applicable

A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide

Terminated
NCT00510783Phase 4

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Completed
NCT00908453Phase 3

The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7